Insurance by BogdanovaThe Encyclopedia of Insurance and Risk Science

RESEARCH DOSSIER

Statutory Sickness Cash Benefits and Certified Absence

Abstract. Statutory sickness cash benefits protect income when a health condition temporarily reduces a person's capacity to perform remunerated work. Their actual operation depends on a chain of institutional judgments: legal attachment to a protected population, recognition of a qualifying incapacity, notification and medical certification, assignment of employer and public payment responsibility, computation of a benefit, continued evidence of incapacity, and the eventual transition to work, rehabilitation, another benefit, or exhaustion. This monograph examines that chain through international labor standards, contemporary national law, administrative practice, official statistical evidence, and empirical research. It distinguishes sickness cash benefits from healthcare access, paid sick time, wage continuation, occupational injury, long-term disability, and job-protected leave. The comparison concentrates on Germany, Great Britain, Sweden, the Netherlands, and the United States, while situating their arrangements within International Labour Organization standards and European social-security coordination. Original analysis specifies the interaction of waiting periods, certification thresholds, payment ceilings, duration limits, and payer changes; offers a transparent illustrative benefit calculation and an expected-expenditure expression; and identifies what administrative statistics and quasi-experimental estimates can establish. The central conclusion is that protection depends on the timing and reliability of the entire payment-and-verification process. A nominal statutory replacement rate, considered alone, cannot measure income security, fiscal allocation, work participation, or fairness.

Keywords: Statutory sickness benefit; sickness cash benefits; certified absence; incapacity for work; medical certificate; fit note; wage continuation; employer liability; social insurance; waiting period; benefit duration; work rehabilitation; social protection; labor-market institutions; actuarial expenditure; comparative social security.

Introduction

A worker's loss of earnings during illness is a joint medical, employment, and social-security event. Illness may reduce work capacity; employment terms determine the opportunity to earn; statutory rules define eligible absence and compensation; clinicians or other authorized professionals provide evidence; and employers or public institutions assess and pay claims. Even the expression sick leave has different meanings across jurisdictions. It can describe permission to be absent, contractual pay during absence, a legal wage-continuation obligation, short-period public sickness insurance, or a longer pathway toward disability support. Treating those objects as interchangeable distorts historical comparisons and fiscal estimates.

This dossier addresses the precise subject approved within the Science of Social Insurance and Public Protection: income replacement during temporary incapacity and the evidentiary governance of certified absence. The governing research question is how certification, payment duration, and employer–public coordination jointly shape effective protection. The analysis uses contemporaneous official instruments, national statutes and administrative guidance, a public survey, an ILO global statistical synthesis, OECD comparative research, and one explicitly identified quasi-experimental study. Legal statements are dated to the documents examined as of November 17, 2026; policy design differs across jurisdictions and may change. Cross-national illustrations describe national rules and do not imply that any one country's practice is required by another's law.

The unit of analysis is first the sickness spell, defined as a period of medically or administratively recognized work incapacity subject to the relevant scheme's recurrence rules. Other units include the individual claimant, protected employee, employer, benefit-day, public insurer, and calendar-year expenditure. Each gives a different denominator and inferential question. A spell can be medically valid yet unpaid because of a waiting period; compensated yet never recorded as a public cash-benefit claim because the employer remains liable; or certified without being counted in a workforce survey's reported absences. The distinction is fundamental to every chapter that follows.

Conceptual and Historical Foundations

The protected contingency and the nature of the benefit

The ILO's Social Security Convention No. 102 (1952), Part III, defines the sickness-benefit contingency in Article 14 as incapacity for work resulting from a morbid condition and involving suspension of earnings, as defined by national law. Article 15 specifies alternative minimum protected-population tests; Article 16 concerns a periodical cash payment; and Article 18 permits a 26-week limit per case and an initial three-day nonpayment period under its ordinary conditions, with a narrower exception for certain declarations. These provisions establish a comparative legal standard whose force for any particular country depends on ratification, accepted Parts, and implementation. They are not a universal benefit schedule automatically payable to every worker.

The subsequent Medical Care and Sickness Benefits Convention No. 130 (1969) expands the framework for states bound by the relevant obligations. Its Articles 18 and following concern cash sickness benefits; Article 23 specifies a 60% benchmark for a defined standard beneficiary using a prescribed reference-wage methodology; Article 26 generally permits limitation to no less than 52 weeks per incapacity and an initial waiting period no longer than three days, subject to the instrument's exceptions. An ILO reference wage is analytically distinct from the uncapped individual claimant's net-pay replacement rate. Comparing a convention's standard-beneficiary percentage with the headline percentage of a national scheme requires reconstructing the relevant wage, family allowance, cap, and tax treatment.

The Social Protection Floors Recommendation No. 202 (2012) addresses nationally defined basic income security for people of working age unable to earn sufficient income, including through sickness. It articulates access, adequacy, predictable benefits, law-based entitlements, and accessible complaints and appeals. Recommendations guide policy; conventions create obligations under their own applicable ratification conditions. Together they show how sickness protection can be organized through insurance contributions, statutory employer responsibility, tax financing, or combinations of those institutions.

Four operational categories must be distinguished. Job-protected absence establishes a right to time away from work or to reinstatement under specified conditions. Wage continuation obliges an employer to maintain all or part of wages during a period of illness. Statutory sickness cash benefit is an income-replacement entitlement defined by law; it may be paid by an employer as statutory sick pay or by a social insurance institution. Supplementary occupational or private cover can increase the amount or duration without replacing the statutory baseline. A healthcare benefit pays for services or grants access to care; an employment-injury benefit is generally tied to occupational causation; long-term disability support may apply a different work-capacity threshold and duration test. These separations make the institutions measurable.

Historical development and the changing division of responsibility

European industrialization exposed the fragility of wages during illness and stimulated mutual funds, sickness societies, and compulsory coverage. The German social-insurance legislation of 1883 became an influential point of expansion; the German pension-insurance historical chronology places sickness insurance in 1883 and accident insurance in 1884. Early comparisons must nevertheless recognize national and occupational differences. Alfred Manes's analysis of social-insurance benefits (1925) treated qualification, duration, overlapping benefits, and legal entitlement as distinct components of compulsory systems. Those questions remain central a century later even though covered populations, clinical practice, and financing have changed.

The modern evolution is characterized by several contemporaneous processes: extending formal eligibility beyond selected industrial occupations; deciding how much first-spell cost should rest with employers; using medical assessments to substantiate temporary incapacity; developing reintegration and partial-work arrangements; and coordinating short-term payment with longer-term disability programs. The OECD's cross-country synthesis (2010) emphasizes the roles of workers, employers, physicians, benefit authorities, and service providers in preserving employment. Its arguments are institutional comparisons, not a universal estimate that any one certification rule lowers absence by a fixed percentage.

Coverage and the measurement of protection

The ILO's World Social Protection Report 2024–26 estimates that 56.1% of the global labor force, representing 34.4% of the working-age population, had legal sickness-benefit coverage under its reporting definitions; the complementary estimate of 4.1 billion working-age persons without such legal protection has the working-age population as its denominator. These are modeled global legal-coverage figures, not a direct census of paid sickness spells or a measured incidence of illness. The report's sickness-protection comparative chapter separately documents legal benefit level and duration among 172 countries with available information. It identifies 71 countries in the category of at least 60% of past earnings and at least 26 weeks under the report's own table definition. This descriptive threshold should not be equated automatically with the legal compliance test under Convention No. 102, whose method and contingencies differ.

Legal coverage, effective receipt, adequacy, and continuity answer separate questions. Legal coverage describes the fraction of a defined population potentially protected; effective receipt requires observing qualifying events and payment; adequacy requires a base, tax treatment, family circumstances, and expenditure needs; continuity considers the gap between medical absence and funds arriving. A program can improve the first quantity without improving the other three to the same extent. Surveyed illness prevalence is also not the same as a claim rate: long absences, multiple spells, and working while sick may be recorded differently. Any scientifically responsible comparison states exactly which quantity was measured.

Incapacity Certification

The legal and clinical object of certification

Certification translates a clinical judgment into evidence relevant to a particular person's work. The underlying medical condition, the functional restriction, the demands of a job, the expected time course, and the legal definition of eligible incapacity are related but individually examinable. A diagnosis alone may give insufficient evidence of whether modified duties are possible. Conversely, certain work limitations can prevent a person from performing a specific job while permitting other tasks. Administrative certification necessarily involves decisions about who may certify, how soon a note is required, the date from which it applies, the interval for renewal, and who sees its contents.

In Great Britain, official guidance on taking sick leave allows self-certification for sickness lasting seven calendar days or fewer and normally requires a fit note when illness extends beyond seven days. The recognized issuing professionals include doctors, nurses, occupational therapists, pharmacists, and physiotherapists operating within the stated rules. The note can indicate not fit for work or may be fit for work with advice about changed hours or duties. Where no suitable change is agreed, the guidance treats the person as not fit for work. The fit note is therefore an evidence and communication instrument whose employment consequences depend partly on whether the workplace can implement the recommended adjustment.

The UK's fit-note reform began in 2010. The Department for Work and Pensions' evaluation of the 2022 reforms describes the broadening of eligible certifying professionals and the intended role of functional advice. It is an evaluation of administrative reform and stakeholder experience, not conclusive evidence that expanding issuer groups necessarily reduces medically appropriate absence. The same report distinguishes self-declaration during the first seven days from evidence supplied thereafter. A separate 2024–25 worker survey found that 52% of employees reporting a sickness absence had been required to provide a fit note after day seven, while 12% reported a requirement on or before day seven. These figures are self-reported experiences among absentees, not the formal legal distribution of every employer's certification rule.

Germany's Continued Remuneration Act, particularly section 5, requires prompt notice to the employer and generally addresses certification when incapacity lasts more than three calendar days, while allowing the employer to demand evidence sooner. The special arrangements for statutory health insurance include electronic transfer. Official German federal guidance on eAU explains that the clinical practice transmits an electronic incapacity certificate to the health insurer, from which the employer can retrieve the relevant confirmation. The employee retains an obligation to report absence. Electronically exchanging evidence and establishing the right to payment are separate administrative events.

Sweden presents a different sequence. The Swedish Social Insurance Agency's employer guidance requires an employee to notify the employer on day one and ordinarily supply a doctor's certificate on day eight. During the initial fourteen-day employer period, the employer assesses work incapacity in relation to ordinary or available comparable tasks. The agency's medical-certificate guidance explains the role of the certificate in supporting sickness-benefit assessment after the initial period. Earlier certification can be required in specified circumstances. Thus the seventh-day line in Sweden and the UK resembles a common administrative threshold but sits inside distinct benefit and employer obligations.

In the Netherlands, sickness notification initiates occupational-health and reintegration procedures; the Dutch employer reporting rules direct employers to an occupational physician or occupational health service, and restrict requests for medical details about the illness or its cause. This arrangement separates the employer's need to know work capacity and expected return from confidential clinical particulars. The country illustrates why an administratively valid disability or work-capacity certificate should not automatically be a complete medical record available to the payer or manager.

Certification as measurement, evidence, and governance

A certification threshold influences more than the number of notes issued. It alters the cost of seeking clinical assessment, the timing of employer reporting, the proportion of minor spells handled through self-declaration, and the observed case mix entering public claims. Later thresholds can reduce visits for self-limiting illness but may also delay clinical follow-up for a minority of cases. Earlier thresholds may standardize evidence at the expense of administrative work and access costs, particularly where healthcare is difficult to obtain. Neither direction is intrinsically optimal across every population and health condition.

In empirical data, a certificate is the outcome of several filters: an illness occurs; a worker reports and is absent; a duration threshold is reached; care is accessible; an authorized clinician documents work capacity; the correct institution receives evidence; and a claim is processed. The observed rate of certificates is therefore a selected rate, not a disease-incidence rate. For research, certification records require episode linkage, start and end date, partial versus complete absence, clinician role, renewal, administrative refusal, and changes to coding or digitization. An increase in certificate counts after electronic transmission could reflect more complete registration rather than deterioration in health.

The decision-maker also matters. A treating clinician has information about care and symptoms; an occupational physician may be more familiar with task modification; an insurer assesses scheme eligibility; an employer evaluates feasible adjustments. Explicitly separating those functions supports review and appeal and protects medically sensitive information. The right design depends on the institution's assigned legal powers and documented controls, rather than on any abstract preference for a single certifying actor.

Benefit Duration

The duration structure of an eligible sickness spell

Duration is a multidimensional legal rule. A scheme may specify a waiting period before any payment, an employer-paid interval, a public insurer's entry point, a maximum paid duration, recurrence or linkage rules, and a separate test at transition to disability support. The days counted can be calendar days, scheduled working days, qualifying days, or legally defined benefit days. Consequently, a nominal promise of twenty-eight weeks and another of six weeks cannot be compared without identifying the eligible spell and the sequence of payers.

In Great Britain, the Employment Rights Act 2025 SSP provisions took effect for the relevant changes on April 6, 2026. HM Revenue & Customs' transitional sickness guidance identifies removal of the lower earnings requirement and payment from the first full day of sickness; it also governs absences straddling the commencement date. Under the 2026–27 employer rate guidance, the statutory weekly amount is the lower of 80% of average weekly earnings or £123.25. The familiar twenty-eight-week statutory duration is confirmed in current Acas SSP guidance. These are Great Britain SSP rules and should not be retrojected into 2024 survey data, which describes behavior under the earlier qualifying arrangements.

In Germany, the Continued Remuneration Act, section 3 generally provides up to six weeks of employer wage continuation for a qualifying illness and includes detailed rules for recurrence of the same condition and a four-week continuous-employment qualification. The Federal Ministry of Health's Krankengeld explanation states that statutory sickness cash benefit normally follows the employer period, at 70% of regular gross pay subject to the ceiling, but no more than 90% of previous net pay, and that the 78-week limit within a three-year period includes continued remuneration. It is therefore erroneous to add 78 public benefit weeks mechanically to six employer weeks as though both limits were sequential full entitlements in a single case.

In Sweden, the employer-to-agency timeline places employer sick pay in the first fourteen calendar days of the applicable period and the agency sickness-benefit claim from day fifteen, with notifications, medical evidence, and review obligations. The source also describes the employer's return-to-work planning responsibilities. The Dutch UWV wage-continuation guidance specifies wage payment by the employer for up to 104 weeks, generally at least 70% of gross wages, with first-year minimum-wage protection and possible collective-agreement supplements. A public Ziektewet sickness payment operates in certain special cases rather than simply replacing the universal employer obligation. These contrasting schedules demonstrate that employer and public durations must be located on a single common time axis before expenditure can be compared.

Waiting periods, caps, and recurrence

A waiting period concentrates uninsured income loss at the start of a spell, when household liquidity may be especially thin. Its stated aim may be to reduce administration for short spells, contain moral hazard, or allocate minor risks to employees and employers. That design also can encourage attendance while contagious or delay adequate recovery. The net effect depends on behavioral responses and coverage substitutes. In 2026 Great Britain's abolition of SSP waiting days changed one such margin; the factual change does not, by itself, establish its causal effects on national absences or infection rates.

Rate ceilings generate a different distributional pattern. Under a flat maximum, a higher-paid worker receives a lower nominal fraction of prior wages than a lower-paid worker, while a low weekly cap can also leave people with moderate earnings inadequately protected. A minimum tied to wage, household needs, or tax-financed assistance may affect those differences. Amount comparisons need consistent units: gross earnings, net disposable earnings, weekly or monthly calendars, income taxation, employer top-ups, and the person-level or household-level base. Differences in taxable treatment can reverse simple comparisons of headline replacement rates.

Recurrence rules introduce path dependence: a second illness might be a new spell, linked to a prior one, or counted toward a cumulative disease-specific limit. Certification resets do not necessarily reset legal benefit maxima. Benefit-exhaustion rates depend on whether the denominator is all spells, all paid spells, persons ever eligible in a year, or spells surviving an initial duration threshold. Survivor-conditioned duration estimates also face length-biased sampling, because a cross-section overrepresents longer episodes.

An illustrative cash-flow identity

Consider a hypothetical employee who otherwise would earn $100 on each of thirty scheduled payable workdays. Assume two initial unpaid days; ten subsequent days paid by the employer at 80%; and eighteen subsequent days paid by a public fund at 60%, with neither tax nor wage ceiling. This is an artificial example in uniform workday units, not the law of any country. The earnings benchmark is $3,000. Employer payments equal $800, public payments equal $1,080, and combined support equals $1,880, or 62.67% of the earnings benchmark. If the two unpaid days instead become two additional public-paid days without changing the ten employer-paid days, combined payments rise to $2,000, or 66.67%. The difference is $120, exactly 2 × $100 × 60%. The example isolates waiting-period incidence; it makes no assumption about how spell frequency or duration would change under the alternative rule.

More generally, for a spell of length T in common benefit-day units, define c(d) as the eligibility-and-certification indicator for day d, w as the number of unpaid qualifying days, e(d) and p(d) as mutually exclusive employer and public payment indicators, W(d) as the applicable earnings base, r_e and r_p as payment fractions, and K_e and K_p as monetary ceilings. The benefit cash flow can be written as

B(T)=∑d=1T1(d>w)c(d)[e(d)min⁡{reW(d),Ke}+p(d)min⁡{rpW(d),Kp}].B(T)=\sum_{d=1}^{T}{\bf1}(d>w)c(d)\left[e(d)\min\{r_eW(d),K_e\}+p(d)\min\{r_pW(d),K_p\}\right].

For an incidence count N and a distribution of eligible spell lengths, expected public cash cost in the simplified no-discounting case is

E⁡[Cp]=N∑d=1DPr⁡(T≥d)E⁡[c(d)p(d)min⁡{rpW(d),Kp}∣T≥d],\operatorname{E}[C_p]=N\sum_{d=1}^{D}\Pr(T\ge d)\operatorname{E}[c(d)p(d)\min\{r_pW(d),K_p\}\mid T\ge d],

where D is the scheme's payable-duration ceiling. This is an accounting decomposition, not a new behavioral theory or an estimated national model. Discounting, calendar conversion, contribution flows, taxation, partial return to work, recurrence, correlated earnings and duration, administrative cost, and interactions with other transfers can be included when the relevant observations exist. Treating the probability of certification as an independent constant would generally be inappropriate: certification changes with duration, health severity, occupation, and access to clinicians.

Employer–Public Coordination

Who owes the money, who administers it, and who carries risk?

Institutional responsibility has at least five dimensions: the legal obligor, the immediate paying agent, the ultimate source of finance, the assessor of medical evidence, and the party responsible for work accommodation. These may coincide but need not. A statutory employer payment can be financed entirely by employers, offset through a public reimbursement mechanism, or supplemented by occupational arrangements. A public insurer can make direct transfers while requiring the employer to submit payroll information and certify absences. An employer-funded system can still have public adjudication of some categories. Country labels such as insurance-based or employer-liability conceal these operational interfaces if used without a cash-flow and decision map.

Germany illustrates staged responsibility: paid wages are initially governed by employer obligations; longer qualifying absence may lead to statutory health-insurer Krankengeld. Sweden uses an initial employer sick-pay period followed by a public insurance agency's benefit assessment. The Netherlands primarily keeps the wage-continuation obligation with the employer for a much longer period, while specifying occupational health and reintegration duties. Great Britain retains employer payment of statutory SSP under its national rules; the 2026–27 HMRC rate notice explicitly states that employers cannot recover SSP payments from HMRC under the listed recovery arrangements. These are alternative placements of early-spell liability, not interchangeable names for the same public insurance claim.

The United States exposes a different structural limit to international generalization. The U.S. Department of Labor's federal sick-leave guidance states that no general federal paid-sick-leave entitlement applies, while the Family and Medical Leave Act provides eligible workers with up to twelve weeks of unpaid, job-protected leave for defined situations. State and local paid-sick-time rules and some state wage-replacement programs require separate examination; employer plans can add protection. Thus the existence of federal employment protection does not imply the existence of a federal sickness cash benefit, and a state paid-sick-time accrual rule is not necessarily equivalent to an extended temporary-disability wage-replacement program.

Transitions and procedural continuity

The transition from employer payroll to a public sickness insurer is a potential discontinuity even when both statutes are generous. Employer and agency may require different proof, earnings histories, notification forms, periods of computation, and dates of payment. A person can be certified continuously while payment is delayed during transfer. Administrative continuity therefore calls for coherent episode IDs, shared start dates, timely electronic information, clear applicant responsibilities, notice of adjudication, error correction, and accessible appeals. These are organizational implications inferred from the legal sequences documented in the national sources; they are not findings of a measured international trial.

The European social-security coordination regulation, Regulation (EC) No. 883/2004, Article 21, provides for cash sickness benefits in cross-border circumstances under the competent state's legislation and at its expense, with arrangements allowing another state's institution to pay on its behalf. The Commission's explanatory coordination FAQ distinguishes the residence or stay of a worker from the state legally competent to calculate and finance the cash benefit. Coordination preserves an allocated source of legal authority; it does not merge national replacement formulas into an EU-wide cash-benefit amount.

Interfacing with disability protection demands similar specificity. The OECD's Disability, Work and Inclusion (2022) identifies persistent employment and income gaps affecting disabled people and argues for coordination across employment, services, and protection systems. A prolonged sickness episode can culminate in rehabilitation, modified employment, disability assessment, unemployment, or inactivity; those outcomes are different administrative states. Counting every completed sickness benefit as a return to work inflates employment success, while treating all transitions to disability benefit as medical deterioration overlooks assessment and eligibility changes.

Distributional and behavioral consequences

The cost incidence of a sickness scheme is distributed across employees through uninsured gaps and sometimes payroll contributions; employers through statutory wage continuation, occupational supplements, staffing and accommodation; taxpayers through transfers; and contributors through pooled insurance. Longer employer liability may strengthen incentives for prevention and reintegration, but it can also raise the perceived cost of employing workers with expected health limitations. Public pooling spreads the financial shock while possibly weakening the individual firm's direct exposure; it can also place a higher administrative burden on claimants at the handoff. The direction and size of each response depend on labor-market rules, employer size, wage bargaining, clinical access, and enforcement. A comparative legal table cannot establish net employment effects.

Sick-pay access can also create public-health externalities. Pichler, Wen, and Ziebarth's quasi-experimental US study (2021) analyzed state-week administrative data for 2010–2018 using differences in the timing of paid-sick-leave mandates and reported an approximately 11% first-year decline in doctor-certified influenza-like-illness rates after such mandates. Its design supplies evidence about those reforms and recorded health outcomes in the studied period; it does not isolate the independent effect of doctor-certification timing, prove identical effects in European public insurance systems, or guarantee the same estimate in a later epidemic. The outcome and causal treatment must remain as defined by the authors.

Evidence Verification and Sensitivity

Source hierarchy and dating

The evidentiary hierarchy used in this study begins with the exact text and applicability of statutes or treaties, followed by responsible agency guidance for administration, official statistics with stated denominators, peer-reviewed empirical studies with identifiable designs, and comparative institutional analyses. Every legal comparison must identify the governing jurisdiction, effective date, protected class, earnings definition, benefit or wage-continuation base, certification requirement, recurrence rule, and cumulative maximum. Treaty text may provide an international benchmark; ratification and accepted commitments must be examined separately before country-specific compliance is asserted. An agency explainer can summarize a statute but cannot displace statutory text in a conflict.

The 2026 British reform illustrates temporal misclassification risk. The 2024–25 UK survey records employee experiences under the older SSP environment, while HMRC's April 2026 transitional rules describe the implementation of new waiting-day and earnings eligibility rules. A before–after comparison requires both changes in legal rules and a common outcome measurement; these two documents alone do not quantify a reform effect. Similarly, statutory sick pay, occupational sick pay, and an absence without payment are separately reported in the survey, and the resulting percentages refer to sampled individuals with relevant reported absence, not all employees or all workdays.

The ILO's global legal-coverage series describes membership in legally protected categories. The 2024–26 statistical methodology aggregates national sources and distinguishes contributory, employer-liability, and tax-financed configurations. Its legal-coverage denominator is not a validated measurement of all incapacity claims. The global reported 56.1% labor-force coverage figure cannot be subtracted from a national sickness-claim rate to estimate take-up. In addition, the same person can be legally protected by multiple instruments, making uncritical addition of category percentages invalid without an overlap rule.

Measurement and identification threats

Administrative data can provide exact paid days and disbursements, but often miss employer-funded sickness spells when the public agency does not receive the same records. Survey reports can cover those spells but introduce recall error, sampling error, nonresponse, and ambiguous definitions of sick leave. Medical certificates provide clinical or functional evidence but reflect access to care and the threshold for requiring notes. Payroll datasets capture pay continuation but do not consistently distinguish voluntary salary continuation from statutory minima. A complete measurement system requires a documented crosswalk among employer absence episodes, clinical certification, benefit eligibility, public disbursements, appeals, and labor-market transitions.

Observed differences between countries are confounded by age, occupation, sex, health burden, job security, informal employment, reporting culture, labor-force participation, collective agreements, and unemployment. For causal analysis of waiting-day changes, one must consider concurrent reforms, anticipation, coding changes, calendar effects, employer substitution, and changes in health shocks. For fit-note design, selection into certification is an especially serious issue: comparing certified to self-certified employees without accounting for spell duration and severity cannot measure the causal effect of certification on recovery. A robust evaluation should report event-time effects, test pre-trends where appropriate, examine alternative comparison groups, and disclose uncertainty in treatment assignment.

Sensitivity of fiscal interpretation

The illustrative cash-flow model reveals mechanically testable sensitivities. Holding spell length and behavior fixed, removing an unpaid day increases payment only when that day becomes an eligible payable day under another rule. Extending an employer window while reducing a public window can leave total worker compensation unchanged even as public outlays fall; the employer's cost rises by the corresponding amount only if rates and caps align. Raising a payment cap affects individuals whose uncapped formula exceeds the old cap, so the incidence depends on the earnings distribution. Tightening a medical threshold may reduce observed approved cases and increase appeals or unpaid absence without reducing underlying disease incidence. All four conclusions follow from defined accounting relationships; their actual magnitudes require microdata.

A transparent sensitivity register should vary (i) illness incidence, (ii) duration survival curves, (iii) certification probability conditional on duration and severity, (iv) earnings and statutory caps, (v) employer-to-public transitions, (vi) recurrence windows, (vii) part-time and partial-capacity rules, (viii) administrative payment lags, and (ix) taxes and means-tested offsets. One-at-a-time sensitivity can identify arithmetic drivers, while correlated stress scenarios are needed when recessions, epidemics, or occupational conditions simultaneously alter several inputs. Any fiscal estimate should state whether it is gross transfer expenditure, net public fiscal cost, total social cost, or aggregate worker compensation.

A meaningful equity analysis reports the distribution of uninsured first days, uncompensated final days, take-up among formally eligible people, average cash replacement by earnings decile and employment type, and time to first payment. It must attend to intermittent and informal work, multiple jobs, self-employment, and care-related interruptions. Aggregate replacement-rate averages can disguise sharp gaps near eligibility and certification thresholds. The guiding test is whether two otherwise comparable illnesses result in materially different income protection because of institutional attachment and administrative capacity.

Source-specific limits

ILO conventions offer normative text but require jurisdiction-specific ratification analysis. ILO global figures are modeled legal-coverage estimates and may undergo subsequent revision. OECD comparative reports cover broad institutional relationships and do not supply a harmonized microdatabase for the calculations here. The UK survey is an observational report with respondent classifications; its fit-note answers cannot be interpreted as a clinical audit. The Pichler–Wen–Ziebarth estimate concerns US paid-sick-leave mandates and recorded influenza-like illness, not a direct evaluation of statutory certification thresholds. National agency pages supply current administrative descriptions, with special-case exclusions and collective-agreement variations that cannot all be enumerated within a cross-national dossier. No individual claimant dataset was accessed, no private insurance data were used, and no causal national policy estimate was calculated in this monograph.

Scientific Synthesis and Research Agenda

The combined importance of eligibility, evidence, time, and payment

The source comparison supports a specific institutional conclusion: a legal right to income replacement becomes effective through a sequence of timed and evidentiary conditions. Its relevant components are the entry into protected status, onset of incapacity, employer notification, possible self-certification, professional evidence when required, payer-specific adjudication, disbursement, review, and exit. An interruption at any stage may reduce actual cash received even when the published statutory percentage is generous. For scientific comparison, that chain should be described in the order experienced by the worker and reconciled with the responsibilities recorded by the employer and public agency.

The four examined European arrangements place liability at different points. Germany uses a relatively short employer wage-continuation period before statutory health-insurer cash support; Sweden uses a shorter initial employer stage and a public sickness-benefit application; the Netherlands maintains extended employer remuneration and reintegration responsibility; Great Britain has a statutory employer-paid benefit subject to a national formula, modified materially in April 2026. The United States requires disaggregated federal, state, local, and employer analysis because the general federal statutory paid-sick-leave guarantee is absent. These results are descriptions grounded in checked rules, not a ranking of national systems. A ranking would require comparable evidence about health, income, administrative burden, fiscal transfers, and employment.

A scientifically testable comparative program

Future research can link official records at the level of the spell while preserving privacy and lawful use. A minimum comparable table would record dates of reported illness, first compensated day, first professional certificate, employer payments, public payments, changes in certified work capacity, return-to-work dates, benefit exhaustion, appeal outcomes, and basic employment and earnings characteristics. Country-specific legal metadata would accompany every observation, including the state of the law at the start of the spell and any transition rule. Claims concerning time to payment should use a distribution, including delayed and ultimately denied claims, rather than only the mean among successful claimants.

Three testable hypotheses arise as research questions rather than announced theories. First, when a waiting period is removed without changing certification or the underlying distribution of illnesses, the largest direct income gain should occur in short spells and among employees without occupational top-ups; whether attendance behavior changes remains empirical. Second, when employer and public payers share digital episode records and coordinated deadlines, processing delays at the statutory handoff may decline; measuring this demands observed application and payment timestamps and a plausible counterfactual. Third, expansion of functional fit-note advice may increase documented consideration of adjusted work, but its effect on sustained employment requires employer accommodation data and follow-up, not certificate counts alone.

A stronger quasi-experimental design would exploit a known reform with a sharply dated implementation, credible unaffected comparison groups, and common pre- and post-reform definitions. It would test for anticipation and changes in reporting rather than interpret every discontinuity as a health response. Complementary qualitative work can examine whether clinicians, employers, and claimants understand their respective obligations. Distributional modeling should evaluate outcomes for low earners, workers with fluctuating schedules, small-firm employees, migrants, and workers outside contributory schemes. Such a program preserves the distinct legal and administrative structures while producing meaningful comparative evidence.

Editorial and scientific position

The original contribution of this dossier is an integrated, source-traced comparative interpretation of the timing and handoff of sickness income protection, including an explicit accounting decomposition of employer and public payments. The decomposition is an explanatory calculation using established arithmetic and program concepts; no new named theory, doctrine, patented model, or independently validated causal mechanism is claimed. Its value lies in exposing which comparisons are legitimate, which quantities can be identified from available sources, and where empirical data are still required.

Conclusion

Statutory sickness cash benefits are best understood as an income-security process governed by law, evidence, and time. Formal entitlement defines who can claim; certification documents work-related incapacity under locally applicable standards; payment formulas determine amounts; employer and public responsibilities determine the path of funds; and duration, recurrence, and return-to-work rules define the eventual outcome. International conventions provide legally structured benchmarks, while national legislation produces institutionally distinct systems. Contemporary official guidance in Great Britain, Germany, Sweden, the Netherlands, and the United States demonstrates that the same practical problem—income interrupted by illness—can be addressed through materially different divisions of obligations.

The comparative record supports four conclusions. First, legal coverage, cash receipt, replacement adequacy, and payment continuity are distinct empirical targets. Second, certification is a selection and governance mechanism whose observed volume cannot serve as a straightforward measure of illness or program success. Third, waiting periods, caps, and payer transfers jointly determine the worker's actual income path, and fiscal estimates must allocate those payments accurately. Fourth, credible policy evaluation requires dated legal rules, comparable denominators, linked administrative evidence, and carefully bounded causal inference. The next scientific advance in this subject is achievable through better evidence on those relationships. The present monograph completes a fundamental interpretive synthesis of established law and research without postulating a new theoretical system.

References